Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Nov. 8, 2022 /PRNewswire-AsiaNet/ -- -- The Novavax BA.1 vaccine candidate met its primary strain-change endpoint allowing for development of variant vaccines, if necessary-- Novavax' prototype vaccine induced broad immune response against original Wuhan, BA.1, and BA.5 strains--...
Authors: LATEST ASIANET NEWS RELEASES